O'Neill Gilmore Neil
CEO
O'Neill Gilmore Neil has filed 5 SEC Form 4 filings (5 transaction rows) across 1 company, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Sep 4, 2026.
On the most recent filing, O'Neill Gilmore Neil is listed as CEO at Editas Medicine, Inc. Inside the rolling window, O'Neill Gilmore Neil reported no open-market purchases and 4 open-market sales totaling $80K in EDIT. The largest disclosed transaction in the window is a sale of 15,380 EDIT shares on Jun 3, 2026, worth $42K.
Companies traded
Other insiders at EDIT
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$80K
reported sales (SEC code S)
Companies
1
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
| Date | Ticker | Type | Value |
|---|---|---|---|
| Sep 3, 2025 | EDIT | Sale | $15K |
Frequently asked questions
How many SEC Form 4 filings has O'Neill Gilmore Neil made?
O'Neill Gilmore Neil has filed 5 SEC Form 4 filings (5 transaction rows) across 1 company since 2025.
Which companies does O'Neill Gilmore Neil trade?
O'Neill Gilmore Neil has filed SEC Form 4 disclosures for 1 company, including EDIT.
When was O'Neill Gilmore Neil's most recent SEC Form 4 filing?
O'Neill Gilmore Neil's most recent SEC Form 4 filing on Tracefour is dated Sep 4, 2026.
What is O'Neill Gilmore Neil's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, O'Neill Gilmore Neil is listed as CEO.
What is O'Neill Gilmore Neil's total buy and sell value in the current window?
Inside the rolling retention window, O'Neill Gilmore Neil bought $0 and sold $80K based on SEC Form 4 filings.
What was O'Neill Gilmore Neil's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 15,380 EDIT shares on 2026-06-03, worth $42K, per SEC Form 4 filings.